---
layout: page
title: >-
  Breakout Watch: Merger Deal Lifts Stock With 140% Sales Growth To New Buy Zone
date: 2020-10-09 10:06 -0700
author: MATTHEW GALGANI
origin_url: https://www.investors.com/research/ibd-stock-analysis/lvgo-stock-near-new-buy-zone-after-teladoc-merger/
---




**Livongo** ([LVGO](https://research.investors.com/quote.aspx?symbol=LVGO)) and **Teladoc Health** ([TDOC](https://research.investors.com/quote.aspx?symbol=TDOC)) have released a definitive joint proxy statement to merge. LVGO stock is closing in on a new buy point and all-time high, as the boards of both companies have unanimously recommended approval of the deal.




A meeting for all eligible Livongo shareholders is set to take place on Oct. 29.


Founded in 2008 and based in Silicon Valley, Livongo offers a "whole person platform that empowers people with chronic conditions to live better and healthier lives." It began with a focus on diabetes, and has expanded to cover hypertension, weight management and behavioral health.


Teladoc is headquartered in New York and was founded in 2002. Teladoc provides on-demand health care services with over 3,000 board-certified physicians. Both companies are newer IPO stocks to watch. Livongo had its IPO in 2019, while Teladoc went public in 2015.


The two companies expect the [Livongo-Teladoc merger](https://ir.livongo.com/news-releases/news-release-details/teladoc-health-and-livongo-file-definitive-proxy-statement) will create a consumer-centered virtual health care platform covering the full spectrum of health needs. The deal will give consumers a single access point for health care regardless of clinical situation, aimed at driving better outcomes and lower costs.


Subject to approval by Teladoc and Livongo stockholders, the deal is on track to close by the end of Q4 2020. If completed, the companies will [operate under the Teladoc Health name](https://www.mobihealthnews.com/news/teladoc-health-absorbs-chronic-care-company-livongo-185b-merger#:~:text=Digital%20health%20titans%20Teladoc%20Health,company%20Livongo%20at%20%2418.5%20billion.). Once the merger is completed, LVGO stock will stop trading.


Livongo Even Before Merger: Explosive Sales, Rising Earnings
------------------------------------------------------------


Ahead of the proposed merger with Teladoc, Livongo is already driving strong sales growth and a promising rise in EPS growth.


Over the past three years, Livongo has generated average annual revenue growth of 140%. Although that's compared to prior-year quarters that showed a loss, Livongo has also produced triple-digit EPS gains over the past three quarters. The company has gone from a 6-cents-per-share loss in Q3 2019, to an 11 cents per share gain in Q2 2020.


LVGO stock sports a 98 [Composite Rating](https://www.investors.com/ibd-data-stories/companies-now-outperforming-95-of-all-stocks/), meaning it's outpacing 98% of all stocks in terms of key [CAN SLIM traits](https://www.investors.com/ibd-university/can-slim/). Teladoc has a 94 Composite Rating. Livongo is classified in the No. 51-ranked medical products group, of the 197 industries IBD tracks. Teladoc is in the No. 37-ranked medical software industry.


LVGO Stock Sees Continued Health After 370% Gain
------------------------------------------------


Livongo is just shy of a new breakout and all-time high, after already rising 370% from a breakout in April. It's new buy point is 150.10.


Livongo and Teladoc have both tapped into the virtual health care zeitgeist in response to the coronavirus pandemic. The sharp rise in online doctor visits has been driving demand for both LVGO stock and Teladoc.


Teladoc is also nearing a new buy point and all-time high as it consolidates above its [10-week moving average](https://www.investors.com/how-to-invest/stock-chart-reading-for-beginners-trend-moving-averages-support-nvidia-netflix/). The [relative strength lines](https://www.investors.com/how-to-invest/investors-corner/relative-strength-line-gives-crucial-clues-about-stocks-ready-to-make-big-gains/) are solid for both stocks, with LVGO stock just shy of a new 52-week high.



*Follow Matthew Galgani on Twitter at [@IBD\_MGalgani](https://twitter.com/ibd_mgalgani).*


**YOU MIGHT ALSO LIKE:**


[See Which Tech, Retail Stocks The Best Funds Are Scooping Up](https://www.investors.com/etfs-and-funds/mutual-funds/stocks-to-watch-best-mutual-funds-buy-amazon-zoom-video-alibaba-apple-stock/)


[Navigate Changing The Stock Market Using A 3-Step Routine](https://www.investors.com/how-to-invest/investors-corner/investing-in-stocks-start-with-stock-market-investing-routine-routine/?)


[New To Reading Stock Charts? Start Here](https://www.investors.com/how-to-invest/stock-chart-reading-for-beginners/)


[Identify Bases And Buy Points With Pattern Recognition From MarketSmith](https://www.investors.com/product/marketsmith/?artProdLink=MarketSmith)




